Allianz Asset Management GmbH - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 80 filers reported holding CYTOSORBENTS CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2019$661,000
-69.7%
131,472
-60.2%
0.00%
-50.0%
Q2 2019$2,182,000
-13.4%
330,086
-0.8%
0.00%0.0%
Q1 2019$2,520,000
-7.4%
332,870
-1.1%
0.00%
-33.3%
Q4 2018$2,720,000
-39.8%
336,632
-3.9%
0.00%
-25.0%
Q3 2018$4,517,000
+53.8%
350,178
+35.9%
0.00%
+33.3%
Q2 2018$2,937,000257,6700.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Skylands Capital, LLC 1,772,000$13,379,0001.58%
Sargent Investment Group, LLC 856,315$6,465,0001.53%
Avenir Corp 1,366,549$10,317,0000.82%
CM Management, LLC 150,000$1,133,0000.82%
Winning Points Advisors, LLC 136,900$1,035,0000.78%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,397,0000.46%
SECTORAL ASSET MANAGEMENT INC 244,660$1,847,0000.15%
Redmile Group, LLC 1,304,369$9,848,0000.15%
Granahan Investment Management 1,003,546$7,577,0000.14%
ACT CAPITAL MANAGEMENT, LLC 35,000$265,0000.14%
View complete list of CYTOSORBENTS CORP shareholders